Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

• Conditions: Head and Neck Cancer; Esophageal Cancer

• Registration Number: NCT00318604
• Lead Sponsor: Far Eastern Memorial Hospital

Brief Summary

This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Detailed Description

Not available

Study Timeline

• Status Verified: 2006-04
• Study First Submitted: 2006-04-25
• Study First Submitted QC: 2006-04-25
• Study First Posted: 2006-04-27
• Last Update Submitted: 2006-05-11
• Last Update Posted: 2006-05-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Head and neck cancers
• Esophageal cancer
• Undergoing anti-cancer treatments

Exclusion Criteria

• No distant metastasis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified